PENNY STOCK PICK ------ HQNT (profitable, 25M O/S, 73 cents, only about $200K debt per CEO, medical software company, not tech!) Could be a good buy short and long term.
Penny stocks are doing better lately and historically this time of year (when IRS refunds start to come back) make this an interesting time to think about them, especially with the accounting games played by the large caps. I like HQNT for the reasons below. Please see the starter DD below and do your own DD. Huge range over the last 2 years with significant new PR's lately that hopefully will help drive this well over $1.00 soon and much higher (toward old highs in the future). If nothing else, a good one to watch or consider buying if it pulls back.
CHART: Notice positive money flow and momentum lately
bigcharts.marketwatch.com
I mentioned this before and it is up about 10 cents from where I mentioned. Money flow and momentum have been strongly positive recently, as I said, but big volume has not started, at least yet. It may be worth watching as many feel it is undervalued on current fundamentals and especially on future potential (as the new $5M product annoncement would hugely increase revenues if management is correct in their assessment. Here is some DD to get you started. It may pull back a little, but it may also be poised to get back over $1.00 in the near future, too.
RECENT DEVELOPMENTS
** Announced $5M projected Net for LabQuotient (see PR below) This would dramatically increase revenues by 300% or more, so worth noting.
** Added two very high quality team members recently (who presumably did their own DD on the company)
(1) Dr. Thomas Laipply, Dir. Of Molecular Tissue Pathology, Nichols Institute at Quest Diagnostics (see recent P.R. below) and share purchases on the open market.
(2) Laurence Burden, V.P. of Operations to help market HQNT’s software products. Look at his resume (from recent PR below)
- "As corporate VP and Chief Information Officer (CIO) and member of the turnaround team, he helped make possible the $2.3 billion sale of Firestone to Bridgestone" Also, "As Senior VP and CIO of Freddie Mac, he redesigned its computer systems and financial engineering systems, providing the basis for hundreds of millions in revenues and savings."
OTHER INFO
** Very little debt (about $200K per CEO) unlike most penny stocks
** Good net worth (unlike most penny stocks for sure)
** Shares O/S = 25M (12M float – 4M “true float” – per CEO)
** Good history of stock success at much higher prices, yet fundamentals probably stronger than ever (but that’s for you to decide)
FILING INFO AND RECENT NEWS:
Nine Months Ended September 30, 2001 - nest filing due in about 2 weeks per CEO
Please verify yourself these and other figures below and new filing when it comes out. The company is impressive enough for its small market cap, but they are excited about is the future, the people now on board, their state-of-art software and recent PR regarding their new LabQuotient product of $5M projected "Net" over the next 16-18 months
Total revenues 1,136,149 vs. 1,046,704 (for 9 months ending 9/30/00) but they just had their PR which projects another $5M "net". This is the key new reason to consider this as a timely purchase, IMHO, since it would dramatically increase revenues by 300-400% or more over the next year or two.
Net income diluted EPS = .03
Shares O/S = 25M approx.(per CEO)
True Float = about 4M (another 8M tightly held, I’m told) by the CEO, making 12M)
Two year high:$6+
New filing in about 2 weeks per CEO. You may want to check that before investing, but it the rrecent $5M projection earnings that make this stock interesting, as that could triple revenues this year or more.
DISCLAIMER --- ALWAYS DO YOUR OWN DD
As always, please do your own DD. I believe my facts and figures are right but you should check and verify everything. Also, I am helping give the company some exposure for 30 days and getting paid some restricted one year stock compensation. That compensation is not based on stock price performance and is totally untradeable for a year. I want all to understand that I have owned this stock in the past and bought some last week before I ever knew about this. I’ll give full details if you want them before you invest. Just PM me.
H-Quotient, Inc., Announces LabQuotient; $5 Million Net Projected
VIENNA, Va., Mar 25, 2002 /PRNewswire-FirstCall via COMTEX/ -- H-Quotient, Inc., (OTC Bulletin Board: HQNT chart, msgs) and Dr. Thomas C. Laipply, MD, FCAP, FIAP, Director of Molecular Tissue Pathology, Nichols Institute at Quest Diagnostics announced LabQuotient, a relational database for improving and monitoring medical test ordering. The product is expected to be ready for market this summer.
Pre-production orders have been received. Further details will be announced in a subsequent release.
H-Quotient, Inc., is projected to earn net income of $5 million in the product's first year. All income will be recurring and is expected to grow substantially because the universe for this revolutionary product includes clinical doctors, dentists, veterinarians, emergency rooms, urgent care centers, insurance companies, HMOs, hospital quality assurance personnel, commercial laboratories, and pharmaceutical-drug companies.
****
H-Quotient, Inc., Announces Appointment of Laurence T. Burden As V.P. of Operations ---- Check his resume)
siliconinvestor.com
****
H-Quotient, Inc., Announces More Than 1 Million Shares Purchased by Dr. Laipply
siliconinvestor.com
****
H-Quotient, Inc. Announces LabQuotient Prototype; Full-Scale Sales Effort to Commence
siliconinvestor.com
****
H-Quotient, Inc., Announces Development of Blood Utilization Software
siliconinvestor.com
****
OTHER NEWS
siliconinvestor.com
Do your own DD. You may want to call Doug Kohn, the CEO, at 703-821-3434 |
